Exact Sciences Corporation

NASDAQ:EXAS

65.54 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 2,499.7662,084.2791,767.0871,491.391876.293454.462265.98999.37639.4371.7984.1444.1444.1635.3444.758-0.8672.9354.754.254.9352.9010.8970.051000
Cost of Revenue 654.2574.394458.757354.324216.717117.98279.19645.19524.5014.325000.0240.0240.020.0011.1860.8090.5660.4870.0220.0090-0.40400
Gross Profit 1,845.5661,509.8851,308.331,137.067659.576336.48186.79354.18114.936-2.5274.1444.1444.1395.324.738-0.8681.7493.9413.6844.4482.8790.8880.0510.40400
Gross Profit Ratio 0.7380.7240.740.7620.7530.740.7020.5450.379-1.405110.9940.9960.9961.0010.5960.830.8670.9010.9920.991404,14300
Reseach & Development Expenses 425.882393.418385.646554.052139.69468.2142.13933.47333.91428.66927.67842.13121.9689.0234.2132.0344.8876.7357.84310.90117.08419.98913.3355.3323.6892.849
General & Administrative Expenses 1,416.4737.304801.262481.716352.453178.293109.0476.89857.9530.43513.6499.98.1376.339.516.4698.53210.70210.84912.74214.63311.74412.866000
Selling & Marketing Expenses 203.9846.011861.889589.919385.176249.448153.924112.82682.1438.9089.5784.7552.8571.7930.22600.9914.4335.6180000000
SG&A 1,620.31,583.3151,663.1511,071.635737.629427.741262.964189.724140.0969.34323.22714.65510.9948.1239.7366.4698.53210.70210.84912.74214.63311.74412.8664.8141.561.17
Other Expenses 92.781110.69495.00169.73316.0350107.59704.11.600000000000005.21800
Operating Expenses 2,059.9152,087.4272,143.7981,695.42893.358495.951305.103223.197174.00498.01250.90556.78632.96217.14613.9498.50313.41917.43718.69223.64331.71731.73326.20110.555.2634.021
Operating Income -215.012-577.542-835.468-558.353-233.782-159.471-118.31-169.016-159.068-100.539-46.761-52.642-28.823-11.826-9.208-9.973-12.847-14.167-15.634-19.195-28.838-30.845-26.15-10.146-5.263-4.021
Operating Income Ratio -0.086-0.277-0.473-0.374-0.267-0.351-0.445-1.701-4.033-55.917-11.284-12.703-6.924-2.213-1.93511.503-4.377-2.983-3.679-3.89-9.941-34.387-514.064-10,145,76900
Total Other Income Expenses Net 42.416-55.028-7.038-298.752-35.06921.2033.9322.0181.2710.5420.3160.2620.1480.2440.003-0.602-1.177-0.671-0.6260.6720.4980.9622,665.032-3.18400
Income Before Tax -201.746-632.57-842.506-857.105-268.851-175.057-114.584-167.211-157.803-100.048-46.514-52.421-28.675-11.556-9.128-9.741-11.959-12.915-14.52-18.523-28.34-29.883-23,485.425-13.3300
Income Before Tax Ratio -0.081-0.303-0.477-0.575-0.307-0.385-0.431-1.683-4.001-55.644-11.224-12.65-6.888-2.162-1.91811.235-4.075-2.719-3.416-3.753-9.769-33.314-461,675.349-13,329,82200
Income Tax Expense 2.403-9.064-246.881-8.572-184.8580.092-0.187-11.296-7.744-3.659-1.033-0.6820-0.27-0.2970.372.5332.4272.4382.7860.06202,662.3671.737-0.2993.578
Net Income -204.149-623.506-595.625-848.533-83.993-175.149-114.397-167.211-157.803-100.048-46.514-52.421-28.675-11.556-9.089-9.741-11.959-12.915-14.52-18.523-28.34-29.883-23.485-11.883-4.964-3.578
Net Income Ratio -0.082-0.299-0.337-0.569-0.096-0.385-0.43-1.683-4.001-55.644-11.224-12.65-6.888-2.162-1.9111.235-4.075-2.719-3.416-3.753-9.769-33.314-461.675-11,883,11900
EPS -1.13-3.54-3.48-5.61-0.64-1.43-0.99-1.63-1.71-1.25-0.69-0.88-0.55-0.29-0.28-0.36-0.44-0.49-0.55-0.73-1.5-1.62-1.42-8.13-5.32-6.08
EPS Diluted -1.13-3.54-3.48-5.61-0.64-1.43-0.99-1.63-1.71-1.25-0.69-0.88-0.55-0.29-0.28-0.36-0.44-0.49-0.55-0.73-1.5-1.62-1.42-8.13-5.32-6.08
EBITDA -13.133-480.092-740.467-464.955-217.747-159.471-118.31-169.016-159.068-100.539-46.445-52.38-28.412-11.84-9.214-8.143-10.493-12.825-14.382-19.195-28.838-28.687-25.082-6.558-4.839-4.021
EBITDA Ratio -0.005-0.23-0.419-0.312-0.248-0.351-0.445-1.701-4.033-55.917-11.208-12.64-6.825-2.216-1.9379.392-3.575-2.7-3.384-3.89-9.941-31.981-493.064-6,557,57400